In This Section      
Print This Page

Transcatheter Aortic Valve Replacement (TAVR)

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure for patients who need a new aortic valve due to aortic valve stenosis but who are at high risk for open-heart surgery.

appointment icon

Schedule an Appointment

443-997-0270

Transcatheter Aortic Valve Replacement (TAVR): What You Need to Know

Get TAVR information from hopkinsmedicine.org
  • The damaged heart valve is replaced using a valve made of natural tissue obtained from the heart of a pig or cow.
  • The new valve is delivered via catheter, a long, thin tube inserted in an artery and guided to the heart.
  • The catheterization procedure typically takes one to three hours, and patients are up and walking within 24 to 48 hours after the procedure. The typical hospital stay is three to five days.
  • These transcatheter-delivered valves are FDA approved for patients at high risk for conventional open heart surgery.

Patient Resources

 

Recent News and Articles

Johns Hopkins Collaboration Provides Alternative to Open Heart Surgery for DC Region Patients

"A Lower Risk Threshold for TAVR?” featuring cardiac surgeon John Conte and interventional cardiologists Jon Resar and Rani Hasan.
—Published in the Johns Hopkins Heart and Vascular Institute’s Cardiovascular Report